ZA829596B - New bicyclic compounds and a process for the preparation thereof - Google Patents
New bicyclic compounds and a process for the preparation thereofInfo
- Publication number
- ZA829596B ZA829596B ZA829596A ZA829596A ZA829596B ZA 829596 B ZA829596 B ZA 829596B ZA 829596 A ZA829596 A ZA 829596A ZA 829596 A ZA829596 A ZA 829596A ZA 829596 B ZA829596 B ZA 829596B
- Authority
- ZA
- South Africa
- Prior art keywords
- preparation
- bicyclic compounds
- new bicyclic
- new
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
- C07D207/277—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
- C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D411/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
- C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
- C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
- C07D477/18—Oxygen atoms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU814015A HU185491B (en) | 1981-12-30 | 1981-12-30 | Process for producing new azabicyclo-bracket-3.2.0-bracket closedheptane derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA829596B true ZA829596B (en) | 1983-10-26 |
Family
ID=10966521
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA829596A ZA829596B (en) | 1981-12-30 | 1982-12-30 | New bicyclic compounds and a process for the preparation thereof |
Country Status (17)
Country | Link |
---|---|
JP (1) | JPS58118587A (nl) |
AT (1) | AT376982B (nl) |
BE (1) | BE895492A (nl) |
CA (1) | CA1190931A (nl) |
DE (1) | DE3248676A1 (nl) |
ES (1) | ES8501747A1 (nl) |
FI (1) | FI824520L (nl) |
FR (1) | FR2519001B1 (nl) |
GB (1) | GB2114124A (nl) |
GR (1) | GR77070B (nl) |
HU (1) | HU185491B (nl) |
IT (1) | IT1210970B (nl) |
LU (1) | LU84569A1 (nl) |
NL (1) | NL8205067A (nl) |
PL (1) | PL239888A1 (nl) |
SE (1) | SE8207478L (nl) |
ZA (1) | ZA829596B (nl) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5625110A (en) * | 1978-12-18 | 1981-03-10 | Bristol Myers Co | Antibacterial |
IE52147B1 (en) * | 1980-03-27 | 1987-07-08 | Merck & Co Inc | 4-(3-carboxy-2-oxopropyl)-azetidin-2-ones and process for their preparation |
JPS57176982A (en) * | 1981-04-24 | 1982-10-30 | Shionogi & Co Ltd | Dioxolanylazetidinone compound, its preparation and use |
-
1981
- 1981-12-30 HU HU814015A patent/HU185491B/hu not_active IP Right Cessation
-
1982
- 1982-12-10 AT AT0450882A patent/AT376982B/de not_active IP Right Cessation
- 1982-12-28 JP JP57235158A patent/JPS58118587A/ja active Pending
- 1982-12-28 BE BE1/10679A patent/BE895492A/fr not_active IP Right Cessation
- 1982-12-29 SE SE8207478A patent/SE8207478L/xx not_active Application Discontinuation
- 1982-12-29 FR FR8221975A patent/FR2519001B1/fr not_active Expired
- 1982-12-29 LU LU84569A patent/LU84569A1/fr unknown
- 1982-12-30 ZA ZA829596A patent/ZA829596B/xx unknown
- 1982-12-30 GR GR70187A patent/GR77070B/el unknown
- 1982-12-30 CA CA000418742A patent/CA1190931A/en not_active Expired
- 1982-12-30 GB GB08236914A patent/GB2114124A/en not_active Withdrawn
- 1982-12-30 DE DE19823248676 patent/DE3248676A1/de not_active Withdrawn
- 1982-12-30 FI FI824520A patent/FI824520L/fi not_active Application Discontinuation
- 1982-12-30 NL NL8205067A patent/NL8205067A/nl not_active Application Discontinuation
- 1982-12-30 ES ES518723A patent/ES8501747A1/es not_active Expired
- 1982-12-30 IT IT8225063A patent/IT1210970B/it active
- 1982-12-30 PL PL23988882A patent/PL239888A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
FR2519001B1 (fr) | 1985-10-25 |
SE8207478D0 (sv) | 1982-12-29 |
CA1190931A (en) | 1985-07-23 |
FI824520L (fi) | 1983-07-01 |
LU84569A1 (fr) | 1984-10-22 |
GR77070B (nl) | 1984-09-05 |
ATA450882A (de) | 1984-06-15 |
FI824520A0 (fi) | 1982-12-30 |
ES518723A0 (es) | 1984-12-16 |
AT376982B (de) | 1985-01-25 |
GB2114124A (en) | 1983-08-17 |
BE895492A (fr) | 1983-06-28 |
IT8225063A0 (it) | 1982-12-30 |
IT1210970B (it) | 1989-09-29 |
DE3248676A1 (de) | 1983-07-07 |
SE8207478L (sv) | 1983-07-01 |
JPS58118587A (ja) | 1983-07-14 |
ES8501747A1 (es) | 1984-12-16 |
FR2519001A1 (fr) | 1983-07-01 |
HU185491B (en) | 1985-02-28 |
PL239888A1 (en) | 1984-01-02 |
NL8205067A (nl) | 1983-07-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3267557D1 (en) | Process for the preparation of a 5-alkyl-butyrolactone | |
PT74526B (en) | Process for the preparation of new n-acyl-polypeptides | |
DE3372183D1 (en) | A process for the preparation of alpha-6-deoxytetracyclines | |
DE3365572D1 (en) | Process for the preparation of a phenylalkylaminoethylsalicylamide | |
DE3480339D1 (en) | A new process for the preparation of alpha-6-deoxy-tetracyclines | |
HRP930089B1 (en) | PROCESS FOR THE PREPARATION OF SPS-aze | |
DE3280005D1 (en) | Beta-lactam compounds and process for the preparation thereof | |
ZA824809B (en) | New bicyclic compounds and a process for the preparation thereof | |
DE3271851D1 (en) | A filter and a process for the preparation thereof | |
DE3261387D1 (en) | Process for the preparation of 3-alkyl-3-acyloxy-4-hydroxybutenes | |
PT74339B (en) | Process for the preparation of alpha-haloalkylamides | |
GB2111471B (en) | Process for the preparation of acicular -feooh | |
DE3265814D1 (en) | Process for the preparation of halogeno-2-mercaptobenzoxazoles | |
GB2112391B (en) | New bicyclic compounds and a process for the preparation thereof | |
EG16845A (en) | New azapicyclic compounds and a process for the preparation thereof | |
DE3263745D1 (en) | Process for the preparation of 4-aminobutyramide | |
DE3260205D1 (en) | Process for the preparation of 2-chloro-4-nitrotoluene | |
DE3267131D1 (en) | Process for the preparation of a 2-alkylpyrrole | |
GB2101120B (en) | 7a-methoxycephem compounds and process for preparing the same | |
ZA829596B (en) | New bicyclic compounds and a process for the preparation thereof | |
HRP920785A2 (en) | New bicyclic compounds and a process for the preparation thereof | |
GB2149399B (en) | A process for the preparation of 2-hydroxy-5-1-hydroxy-2-(4phenyl-2-bukyl)-amine-ethyl-benzamide | |
DE3263730D1 (en) | Process for the preparation of dihydroxypropyltheophylline | |
IL66819A0 (en) | Process for the preparation of macrophages-activating-factor | |
PT77034B (en) | Process for the preparation of a phenylalkylaminoethylsalicylamide |